Blog Archive
-
▼
2007
(17)
-
▼
October
(8)
- INNATE PHARMA, NEW PHASE IIa TRIAL WITH IPH 1101 I...
- BioAlliance Pharma, promising in vivo results for ...
- Flamel Technologies, Positive Results of a Phase I...
- bioMérieux’s VIDAS® B·R·A·H·M·S PCT® Assay A First...
- VIVALIS , FIRST RESEARCH LICENCE IN THE FIELD OF T...
- Biospace med, Total Solution to Orthopedic Imaging
- bioMerieux , Diagnosis and Prognosis of Heart Failure
- Transgene, therapeutic vaccine candidate TG4040 d...
-
▼
October
(8)
Wednesday, October 10, 2007
Biospace med, Total Solution to Orthopedic Imaging
Oct. 9, 2007 - Biospace med announced that it has received 510k clearance from the Food and Drug Administration (FDA) to market EOS, a new digital Xray imager in the United States for 2D imaging use. EOS 2D|3D technology is part of a total solution to orthopedic imaging allowing images to be obtained with a low dose of radiation and is capable of long length digital imaging, permitting full-body, uninterrupted digital imaging with a single scan...Biospace med's Press Release -